Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP)
The goal of the FSHARP program is to leverage advances in bio-artificial blood substitute technologies to develop field deployable, shelf-stable hemorrhage countermeasures to sustain warfighters and civilian casualties in austere, pre-hospital settings.
Agency: Department of Defense
Office: DARPA - Biological Technologies Office
Estimated Funding: $493,827
Office: DARPA - Biological Technologies Office
Estimated Funding: $493,827
Obtain Full Opportunity Text:
Beta.SAM Contract Opportunities
Additional Information of Eligibility:
All responsible sources capable of satisfying the Government's needs may submit a proposal that shall be considered by DARPA.
See the Eligibility Information section of the BAA for more information.
Full Opportunity Web Address:
https://sam.gov/opp/36db79ac97b0496399f472d5f2d5dd5a/view
Contact:
Agency Email Description:
renee_robichaud@fws.gov
Agency Email:
Date Posted:
2021-05-28
Application Due Date:
Archive Date:
2021-09-09
Social Entrepreneurship
Spotlight
Rwanda as Social Entrepreneur Fund Beneficiary
The Republic of Rwanda has been picked as one of the six African countries as beneficiaries for a new fellowship fund program designed at supporting social entrepreneurs in tackling issues on food security.
Learn How to Identify and Avoid Grant Scams
